Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 11,711 shares at $44.99 ($525K) on 2021-01-25, disclosed to the SEC on 2021-01-27.
Open-market sale of $525k RGNX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.64 | 315 | $13K | 2.6% |
| 2 | $44.05 | 974 | $43K | 8.2% |
| 3 | $44.99 | 5,211 | $234K | 44.6% |
| 4 | $44.99 | 5,211 | $234K | 44.6% |
| Total | $44.85 avg | 11,711 | $525K | 100% |
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |